Interleukin-4 and lnterleukin-13: Their Similarities and Discrepancies

References

• Howard M., Farrar J., Hilfiker M., Johnson B., Takatsu K., Hamaoka T., Paul W. E. Identification of a T-cell derived B cell growth factor distinct from interleukin-2. J. Exp. Med. 1982; 155: 914–921
   PubMed Web of Science ®Google Scholar
• Isacksson P. C., Pure E., Vitetta S., Krammer P. H. Effect on the isotype switch of murine B cells. J. Exp. Med. 1982; 155: 734–748
   Google Scholar
• Yokota T., Otsuka T., Mosmann T., Banchereau J., Defrance T., Blanchard D., de Vries J. E., Lee F., Arai K. Isolation and characterization of a human inter-leukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell-stimulatory activities. Proc. Natl. Acad. Sci. USA 1986; 83: 5894–5898
   PubMed Web of Science ®Google Scholar
• Brown K. D., Zurawski S. M., Mosmann T. R., Zurawski G. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation process. J. Immunol. 1989; 142: 679–687
   PubMed Web of Science ®Google Scholar
• McKenzie A. N.J., Culpepper J. A., de Waal Malefyt R., Brière F., Punnonen J., Aversa G., Sato A., Dang W., Cocks B. G., Menon S., de Vries J. E., Banchereau J., Zurawski G. Interleukin-13, a novel T cell-derived cytokine that regulates human monocyte and B cell function. Proc. Natl. Acad. Sci. USA 1993; 90: 3735–3739
   PubMed Web of Science ®Google Scholar
• Minty A., Chalon P., Derocq J. M., Dumont X., Guillemot J. C., Kaghad M., Labit C., Leplatois P., Liauzun P., Miloux B., Minty C., Casellas P., Loison G., Lupker J., Shire D., Ferrara P., Caput D. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248–250
   PubMed Web of Science ®Google Scholar
• O'Garra A., Spits H. The immunobiology of interleukin 4. Res. Immunol. 1993; 144: 567–643
   Google Scholar
• Brown M. A., Hural J. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 1997; 17: 1–32
   PubMed Web of Science ®Google Scholar
• Zurawski G., de Vries J. E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 1994; 15: 19–26
   PubMedGoogle Scholar
• McKenzie A. N.J., Li X., Largaespada D. A., Sato A., Kaneda A., Zurawski S. M., Doyle E. L., Milatovich A., Francke V., Copeland N. G., Jenkins N. A., Zurawski G. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J. Immunol. 1993; 150: 5436–5444
   PubMed Web of Science ®Google Scholar
• Zurawski S. M., Vega F., Jr., Huyghe B., Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 1993; 12: 2663–2670
   PubMed Web of Science ®Google Scholar
• Sorg R. V., Enczmann J., Sorg U. R., Schneider E. M., Wernet P. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2. Exp. Hematol. 1993; 21: 560–563
   PubMed Web of Science ®Google Scholar
• Atamas S. P., Choi J., Yurovsky V. V., White B. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol. 1996; 156: 435–441
   PubMedGoogle Scholar
• Aversa G., Punnonen J., Cocks B. J., de Waal Malefyt R., Vega F., Zurawski S. M., Zurawski G., de Vries J. E. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 1993; 178: 2213–2218
   PubMed Web of Science ®Google Scholar
• Kruse N., Tony H. P., Sebald W. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J. 1992; 11: 3237–3244
   PubMed Web of Science ®Google Scholar
• Windsor W. T., Syto R., Durkin J., Das P., Reichert P., Pramanik B., Tindall S., Le H. V., Labdon J., Nagabhushan T. L., Trotta P. P. Disulfide bond assignment of mammalian cell-derived recombinant human interleukin 4. Biophys. J. 1990; 57: 423
   Google Scholar
• Minty A. Interleukin-13. Human Cytokines., Handbook for basic and clinical research, B. B. Aggarwal, J. U. Gutterman. Blackwells. 1996; Vol. 2
   Google Scholar
• Walter M. R., Cook W. J., Zhao B. G., Cameron R. P., Ealick S. E., Walter R. L., Reichert P., Nagabhushan T. L., Trotta P. P., Bugg C. E. Crystal structure of recombinant human interleukin-4. J. Biol. Chem. 1992; 267: 20371–20376
   PubMed Web of Science ®Google Scholar
• Powers R., Garrett D. S., March C. J., Frieden E. A., Gronenborn A. M., Clore G. M. Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. Science 1992; 256: 1673–1677
   PubMed Web of Science ®Google Scholar
• Morgan J. G., Dolganov G. M., Robbins S. E., Hinton L. M., Lovett M. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res. 1992; 20: 5173–5179
   PubMedGoogle Scholar
• Smirnov D. V., Smirnova M. G., Korobko V. G., Frolova E. I. Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene 1995; 155: 277–281
   Google Scholar
• Abe E., de Waal Malefyt R., Matsuda I., Arai K., Arai N. An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc. Natl. Acad. Sci. USA 1992; 89: 2864–2868
   PubMed Web of Science ®Google Scholar
• Szabo S. J., Gold J. S., Murphy T. L., Murphy K. M. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells. Mol. Cell. Biol. 1993; 13: 4793–4805
   PubMed Web of Science ®Google Scholar
• Dolganov G., Bort S., Lovett M., Burr J., Schubert L., Short D., McGurn M., Gibson C., Lewis D. B. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23–31. Blood 1996; 87: 3316–3326
   Google Scholar
• Wenner C. A., Szabo S. J., Murphy K. M. Identification of IL-4 promoter elements conferring Th2-restricted expression during T helper cell subset development. J. Immunol. 1997; 158: 765–773
   PubMedGoogle Scholar
• Hodge M. R., Ranger A. M., Charles de la Brousse F., Hoey T., Grusby M. J., Glimcher L. H. Hyperproliferation and dysregulation of IL-4 expression in NF- ATp-deficient mice. Immunity 1996; 4: 397–405
   PubMed Web of Science ®Google Scholar
• Li-Weber M., Krafft H., Krammer P. H. A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer. J. Immunol. 1993; 151: 1371–1382
   Google Scholar
• Li-Weber M., Salgame P., Hu C., Davydov I. V., Krammer P. H. Differential interaction of nuclear factors with the PRE-I enhancer element of the human IL-4 promoter in different T cell subsets. J. Immunol. 1997; 158: 1194–1200
   Google Scholar
• Rooney J. W., Hoey T., Glimcher L. H. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 1995; 2: 473–483
   PubMed Web of Science ®Google Scholar
• Song Z., Casolaro V., Chen R., Georas S. N., Monos D., Ono S. J. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J. Immunol. 1996; 156: 424–429
   PubMed Web of Science ®Google Scholar
• Li-Weber M., Davydov I. V., Krafft H., Krammer P. H. Role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 1994; 153: 4122–4133
   PubMedGoogle Scholar
• Cabrillat H., Galizzi J. P., Djossou O., Arai N., Yokota T., Arai K., Banchereau J. High affinity binding of human interleukin 4 to cell lines. Biochem. Biophys. Res. Commun. 1987; 149: 995–1001
   PubMed Web of Science ®Google Scholar
• Park L. S., Friend D., Sassenfeld H. M., Urdal D. L. Characterization of the human B cell stimulatory factor 1 receptor. J. Exp. Med. 1987; 166: 476–488
   PubMed Web of Science ®Google Scholar
• Obiri N. I., Leland P., Murata T., Debinski W., Puri R. K. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol. 1997; 158: 756–764
   Google Scholar
• He Y. W., Malek T. R. The IL-2 receptor 7c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. J. Immunol 1995; 155: 9–12
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R., Abrams J. S., Zurawski S. M., Lecron J. C., Mohan-Peterson S., Sannjanwala B., Bennett B., Silver J., de Vries J. E., Yssel H. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1, and Th2 T cell clones and EBV-transformed B cells. Int. Immunol. 1995; 7: 1405–1416
   PubMedGoogle Scholar
• Foxwell B. M.J., Woerly G., Ryffel B. Identification of interleukin-4 receptor-associated proteins and expression of both high and low affinity binding on human lymphoid cells. Eur. J. Immunol. 1989; 19: 1637–1641
   PubMed Web of Science ®Google Scholar
• Galizzi J. P., Castle B., Djossou O., Harada N., Cabrillat H., Ait Yahia S., Barrett R., Howard M., Banchereau J. Purification of a 130-kDa T cell glycoprotein that binds human interleukin 4 with high affinity. J. Biol. Chem. 1990; 265: 439–444
   Google Scholar
• Garrone P., Djossou O., Galizzi J. P., Banchereau J. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur. J. Immunol. 1991; 21: 1365–1369
   PubMed Web of Science ®Google Scholar
• Galizzi J. P., Zuber C. E., Harada N., Gorman D. M., Djossou O., Kastelein R., Banchereau J., Howard M., Miyajima A. Molecular cloning of a cDNA encoding the human interleukin-4 receptor. Int. Immunol. 1990; 2: 669–675
   PubMed Web of Science ®Google Scholar
• Idzerda R. L., March C. J., Mosley B., Lyman S. D., Vanden Bos T., Gimpel S. D., Din W. S., Grabstein K. H., Widmer M. B., Park L. S., Cosman D., Beckmann M. P. Human Interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 1990; 171: 861–873
   PubMed Web of Science ®Google Scholar
• Miyajima A., Kitamura T., Harada N., Yokota T., Arai K. Cytokine receptors and signal transduction. Ann. Rev. Immunol. 1992; 10: 295–331
   PubMed Web of Science ®Google Scholar
• Keegan A. D., Nelms K., White M., Wang L. M., Pierce J. H., Paul W. E. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 1994; 76: 811–820
   PubMed Web of Science ®Google Scholar
• Noguchi M., Nakamura Y., Russel S. M., Ziegler S. F., Tsang M., Cao X., Leonard W. J. Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science 1993; 262: 1877–1880
   PubMed Web of Science ®Google Scholar
• Russel S. M., Keegan A. D., Harada N., Nakamura Y., Noguchi M., Leland P., Friedmann M. C., Miyajima A., Puri R. K., Paul W. E., Leonard W. J. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 1993; 262: 1880–1883
   PubMed Web of Science ®Google Scholar
• Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147–157
   PubMed Web of Science ®Google Scholar
• Lin J. X., Migone T. S., Tsang M., Friedmann M., Weatherbee J. A., Zhou L., Yamauchi A., Bloom E. T., Mietz J., John S., Leonard W. J. The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 1995; 2: 331–339
   PubMed Web of Science ®Google Scholar
• Zurawski S. M., Chomarat P., Djossou O., Bidaud C., McKenzie A. N.J., Miossec P., Banchereau J., Zurawski G. The primary binding subunit of the human Interleukin-4 receptor is also a component of the Interleukin-13 receptor. J. Biol. Chem. 1995; 270: 13869–13878
   PubMed Web of Science ®Google Scholar
• Obiri N. I., Debinski W., Leonard W. J., Puri R. K. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for Interleukins 2, 4, 7, 9 and 15. J. Biol. Chem. 1995; 270: 8797–8804
   PubMed Web of Science ®Google Scholar
• Vita N., Lefort S., Laurent P., Caput D., Ferrara P. Characterization and comparison of the Interleukin 13 receptor with the interleukin 4 receptor on several cell types. J. Biol. Chem. 1995; 270: 3512–3517
   Google Scholar
• Matthews D. J., Clark P. A., Herbert J., Morgan G., Armitage R. J., Kinnon C., Minty A., Grabstein K. H., Caput D., Ferrara P., Callard R. Function of the Interleukin-2 (IL-2) receptor γ-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13 and IL-15. Blood 1995; 85: 38–42
   PubMed Web of Science ®Google Scholar
• Smerz-Bertling C., Duschl A. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J. Biol. Chem. 1995; 270: 966–970
   PubMedGoogle Scholar
• Hilton D. J., Zhang J. G., Metcalf D., Alexander W. S., Nicola N. A., Willson T. A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 1996; 93: 497–501
   PubMed Web of Science ®Google Scholar
• Aman M. J., Tayebi N., Obiri N., Puri R. K., Modi W. S., Leonard W. J. cDNA cloning and characterization of the human interleukin 13 receptor α chain. J. Biol. Chem. 1996; 271: 29265–29270
   PubMed Web of Science ®Google Scholar
• Gauchat J. F., Schlagenhauf E., Feng N. P., Moser R., Yamage M., Jeannnin P., Alouani S., Elson G., Notarangelo L. D., Wells T., Eugster H. P., Bonnefoy J. Y. A novel 4-kb interleukin-13 receptor α raRNA expressed in human B. T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur. J. Immunol. 1997; 27: 971–978
   PubMedGoogle Scholar
• Bochner B. S., Klunk D. A., Sterbinsky S. A., Coffman R. L., Schleimer R. P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 1995; 154: 799–803
   PubMed Web of Science ®Google Scholar
• Schnyder B., Lugli S., Feng N., Etter H., Lutz R. A., Ryffel B., Sugamura K., Wunderli-Allenspach H., Moser R. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 1996; 87: 4286–4295
   PubMed Web of Science ®Google Scholar
• Caput D., Laurent P., Kaghad M., Lelias J. M., Lefort S., Vita N., Ferrara P. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J. Biol. Chem. 1996; 271: 16921–16926
   PubMed Web of Science ®Google Scholar
• Billard C., Caput D., Vita N., Ferrara P., Orrico M., Gaulard P., Boumsell L., Bensussan A., Farcet J. P. Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation. Eur. Cytokine Netw. 1997; 8: 19–27
   Google Scholar
• Fernandez-Botran R., Vitetta E. S. A soluble, high-affinity, interleukin-4 binding protein is present in the biological fluids of mice. Proc. Natl. Acad. Sci. USA 1990; 87: 4202–4206
   PubMed Web of Science ®Google Scholar
• Blum H., Wolf M., Enssle K., Rollinghoff M., Gessner A. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. J. Immunol. 1996; 157: 1846–1853
   PubMedGoogle Scholar
• Fernandez-Botran R., Vitetta E. S. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J. Exp. Med. 1991; 174: 673–681
   PubMed Web of Science ®Google Scholar
• Fanslow W. C., Clifford K. N., Park L. S., Rubin A. S., Voice R. F., Beckmann M. P., Widmer M. B. Regulation of alloreactivity in vivo, by IL-4 and the soluble IL-4 receptor. J. Immunol. 1991; 147: 535–540
   PubMed Web of Science ®Google Scholar
• Maliszewski C. R., Morrissey P. J., Fanslow W. C., Sato T. A., Willis C., Devison B. Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. Cell. Immunol. 1992; 143: 434–448
   Google Scholar
• Sato T. A., Widmer M. B., Finkelman F. D., Madani H., Jacobs C. A., Grabstein K. H., Maliszewski C. R. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 1993; 150: 2717–2723
   PubMed Web of Science ®Google Scholar
• Zhang J. G., Hilton D. J., Willson T. A., McFarlane C., Roberts B. A., Moritz R. L., Simpson R. J., Alexander W. S., Metcalf D., Nicola N. A. Identification, purification and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned il-13 receptor and il-4 receptor alpha-chains. J. Biol. Chem. 1997; 272: 9474–9480
   Google Scholar
• Keegan A. D., Ryan J. J., Paul W. E. IL-4 regulates growth and differentiation by distinct mechanisms. The Immunologist 1996; 4: 194–198
   Google Scholar
• Kawahara A., Minami Y., Taniguchi T. Evidence for a critical role for the cytoplasmic region of the interleukin-2 (IL-2) receptor γ chain in IL-2, IL-4, and IL-7 signalling. Mol. Cel. Biol. 1994; 14: 5433–5440
   PubMedGoogle Scholar
• Izuhara K., Harada N. Interleukin-4 (IL-4) induces protein tyrosine phosphorylation of the IL-4 receptor and association of phosphatidylinositol 3-kinase to the IL-4 receptor in a mouse T cell line, HT2. J. Biol. Chem. 1993; 268: 13097–13102
   PubMedGoogle Scholar
• Welham M. J., Learmonth L., Bone H., Schrader J. W. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J. Biol. Chem. 1995; 270: 12286–12296
   PubMedGoogle Scholar
• Witthuhn B. A., Silvennoinen O., Miura O., Lai K. S., Cwik C., Liu E. T., Ihle J. N. Involvement of the Jak-3 Janus kinase in signalling by interleukin 2 and 4 in lymphoid and myeloid cells. Nature 1994; 370: 153–157
   PubMed Web of Science ®Google Scholar
• Yin T., Tsang M. L.S., Yang Y. C. JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J. Mol. Biol. 1994; 269: 26614–26617
   Google Scholar
• Miyazaki T., Kawahara A., Fujii H., Nakagawa Y., Minami Y., Liu Z. J., Oishi I., Silvennnoinnen O., Witthuhn B. A., Ihle J. N., Taniguchi T. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994; 266: 1045–1047
   PubMed Web of Science ®Google Scholar
• Murata T., Noguchi P. D., Puri R. K. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J. Immunol. 1996; 156: 2972–2978
   PubMed Web of Science ®Google Scholar
• Wang H. Y., Zamorano J., Yoerkie J. L., Paul W. E., Keegan A. D. The IL-4- induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK-1 expression in human fibrosarcoma cells. J. Immunol. 1997; 158: 1037–1040
   PubMedGoogle Scholar
• Keegan A. D., Johnston J. A., Tortolani P. J., McReynolds L. J., Kinzer C., O'Shea J. J., Paul W. E. Similarities and differences in signal transduction by interleukin-4 and interleukin 13: analysis of Janus kinase activation. Proc Natl. Acad. Sci. USA 1995; 92: 7681–7685
   PubMed Web of Science ®Google Scholar
• Palmer-Crocker R. L., Hughes C. C., Pober J. S. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J. Clin. Invest. 1996; 98: 604–609
   PubMedGoogle Scholar
• Murata T., Puri R. K. Comparison of IL-13 and IL-4-induced signaling in EBV- immortalized human B cells. Cell. Immunol. 1997; 175: 33–40
   Google Scholar
• Wang L. M., Keegan A. D., Paul W. E., Heidaran M. A., Gutkind J. S., Pierce J. H. IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J. 1992; 11: 4899–4908
   PubMed Web of Science ®Google Scholar
• Wang L. M., Michieli P., Lie W. R., Liu F., Lee C. C., Minty A., Sun X. J., Levine A., White M. F., Pierce J. H. The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction. Blood 1995; 86: 4218–4227
   Google Scholar
• Koettnitz K., Kalthoff F. S. Human interleukin-4 receptor signalling requires sequences contained within two cytoplasmic regions. Eur. J. Immunol. 1993; 23: 988–991
   PubMedGoogle Scholar
• Schnyder B., Lahm H., Woerly G., Odartchenko N., Ryffel B., Car B. D. Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1. Biochem. J. 1996; 315: 767–774
   PubMed Web of Science ®Google Scholar
• Harada N., Yang G., Miyajima A., Howard M. Identification of an essential region for growth signal transduction in the cytoplasmic domain of the human interleukin-4 receptor. J. Biol. Chem. 1992; 267: 22752–22758
   PubMedGoogle Scholar
• Musso T., Varesio L., Zhang X., Rowe T. K., Ferrara P., Ortaldo J. R., O'Shea J. J., McVicar D. W. IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. J. Exp. Med. 1994; 180: 2383–2388
   PubMed Web of Science ®Google Scholar
• Hou J., Schindler U., Henzel W. J., Ho T. C., Brasseur M., McKnight S. L. An interleukin-4-induced transcription factor: IL-4 stat. Science 1994; 265: 1701–1706
   PubMed Web of Science ®Google Scholar
• Quelle F. W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S. M., Cleveland J. L., Pierce J. H., Keegan A. D., Nelms K., Paul W. E., Ihle J. N. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 1995; 15: 3336–3343
   PubMed Web of Science ®Google Scholar
• Schindler U., Wu P., Rothe M., Brasseur M., McKnight S. L. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 1995; 2: 689–697
   PubMed Web of Science ®Google Scholar
• Ohmori Y., Smith M. F., Hamilton T. A. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J. Immunol. 1996; 157: 2058–2065
   Google Scholar
• Kaplan M. H., Schindler U., Smiley S. T., Grusby M. J. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996; 4: 313–319
   PubMed Web of Science ®Google Scholar
• Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M. Essential role of Stat6 in IL-4 signalling. Nature 1996; 380: 627–630
   PubMed Web of Science ®Google Scholar
• Takeda K., Kamanaka M., Tanaka T., Kishimoto T., Akira S. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 1996; 157: 3220–3222
   PubMed Web of Science ®Google Scholar
• Shimoda K., van Deursen J., Sangster M. Y., Sarawar S. R., Carson R. T., Tripp R. A., Chu C., Quelle F. W., Nosaka T., Vignali D. A.A., Doherty P. C., Grosveld G., Paul W. E., Ihle J. N. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630–633
   PubMed Web of Science ®Google Scholar
• Lai S. Y., Molden J., Liu K. D., Puck J. M., White M. D., Goldsmith M. A. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J. 1996; 15: 4506–4514
   PubMedGoogle Scholar
• Izuhara K., Heike T., Otsuka T., Yamaoka K., Mayumi M., Imamura T., Niho Y., Harada N. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J. Biol. Chem. 1996; 271: 619–622
   PubMedGoogle Scholar
• Kotanides H., Reich N. C. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 1993; 262: 1265–1267
   PubMedGoogle Scholar
• Kohler I., Alliger P., Minty A., Caput D., Ferrara P., Holl-Neugebauer B., Rank G., Rieber E. P. Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL-4 sharing a DNA binding motif with an interferon-gamma-induced nuclear binding factor. FEBS. Lett. 1994; 345: 187–192
   Google Scholar
• Schindler C., Kashleva H., Pernis A., Pine R., Rothman P. STF-IL-4: a novel IL-4-induced signal transducing factor. EMBO J. 1994; 13: 1350–1356
   PubMedGoogle Scholar
• Izuhara K., Feldman R. A., Greer P., Harada N. Interaction of the c-fes, proto-oncogene product with the interleukin-4 receptor. J. Biol. Chem. 1994; 269: 18623–18629
   PubMed Web of Science ®Google Scholar
• Izuhara K., Feldman R. A., Greer P., Harada N. Interleukin-4 induces association of c-fes, proto-oncogene product with phosphatidylinositol-3 kinase. Blood 1996; 88: 3910–3918
   PubMed Web of Science ®Google Scholar
• Finney M., Guy G. R., Michell R. H., Gordon J., Dugas B., Rigley K. P., Callard R. E. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur. J. Immunol. 1990; 20: 151–156
   PubMed Web of Science ®Google Scholar
• Sozzani P., Cambon C., Vita N., Seguelas M. H., Caput D., Ferrara P., Pipy B. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J. Biol. Chem. 1995; 270: 5084–5088
   Google Scholar
• Justement L., Chen Z. Z., Harris L. K., Ransom J. T., Sandoval V. S., Smith C., Rennick D., Roehm N., Cambier J. BSF-1 induces membrane protein phosphorylation but not phosphoinositide metabolism, Ca2+ mobilization, protein kinase C translocation, or membrane depolarization in resting murine B lymphocytes. J. Immunol. 1986; 137: 3664–3670
   PubMedGoogle Scholar
• Arruda S., Ho J. L. IL-4 receptor signal transduction in human monocytes is associated with protein kinase C translocation. J. Immunol. 1992; 149: 1258–1264
   Google Scholar
• Dokter W. H.A., Sierdsema S. J., Esselink M. T., Halie M. R., Vellenga E. Interleukin-4-mediated inhibition of c-fos, mRNA expression: Role of the lipoxygenase directed pathway. Leukemia 1994; 8: 1181–1184
   Google Scholar
• McGarvie G. M., Cushley W. The effect of recombinant interleukin 4 upon protein kinase activities associated with murine and human B lymphocyte plasma membranes. Cell Signal 1989; 1: 447–460
   Google Scholar
• Mire-Sluis A. R., Thorpe R. Interleukin-4 proliferative signal transduction involves the activation of a tyrosine-specific phosphatase and the dephosphorylation of an 80-kDa protein. J. Biol. Chem. 1991; 266: 18113–18118
   Google Scholar
• Jung T., Wijdenes J., Neumann C., de Vries J. E., Yssel H. Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12. Eur. J. Immunol. 1996; 26: 571–577
   Google Scholar
• Minty A., Asselin S., Bensussan A., Shire D., Vita N., Vyakarnam A., Wijdenes J., Ferrara P., Caput D. The related cytokines IL-13 and IL-4 are distinguished by differential production and differential effects on T lymphocytes. Eur. Cytokine Netw. 1997, In press
   Google Scholar
• Mosmann T. R., Coffman R. L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 145–173
   PubMed Web of Science ®Google Scholar
• Van Der Pouw Kraan T. C., Boeije L. C., Troon J. T., Rutschmann S. K., Wijdenes J., Aarden L. A. Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J. Immunol. 1996; 156: 1818–1823
   Google Scholar
• Alzona M., Jäck H. M., Fisher R. I., Ellis T. M. CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 1994; 153: 2861–2867
   PubMed Web of Science ®Google Scholar
• Del Prete G., Maggi E., Pizzolo G., Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol. Today 1995; 16: 76–80
   PubMedGoogle Scholar
• Schandene L., Ferster A., Mascart-Lemone F., Crusiaux A., Gerard C., Marchant A., Lybin M., Velu T., Sariban E., Goldman M. T helper type 2-like cells and therapeutic effects of interferon–gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur. J. Immunol. 1993; 23: 56–60
   PubMed Web of Science ®Google Scholar
• Sunder-Plassmann R., Majdiç O., Knapp W., Holler W. High IL-4 production is a stable phenotype of CD8neg CD45RAneg CD27neg T cells. Cell. Immunol. 1995; 160: 309–313
   Google Scholar
• Autran B., Legac E., Blanc C., Debré P. A ThO/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. J. Immunol. 1995; 154: 1408–1417
   Google Scholar
• Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D. H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 1997; 185: 825–831
   PubMed Web of Science ®Google Scholar
• Szabo S. J., Dighe A. S., Gubler U., Murphy K. M. Regulation of the interleukin (IL)-12R /V2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 1997; 185: 817–824
   PubMed Web of Science ®Google Scholar
• Gajewski T. F., Joyce J., Fitch F. W. Anti-proliferative effect of IFN-γ in immune regulation III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-γ. J. Immunol. 1989; 143: 15–22
   PubMed Web of Science ®Google Scholar
• Peleman R., Wu J., Fargeas C., Delespesse G. Recombinant interleukin-4 suppresses the production of interferon γ by human mononuclear cells. J. Exp. Med. 1989; 170: 1751–1756
   PubMed Web of Science ®Google Scholar
• Coffman R. L., Varkila K., Scott P., Chatelain R. Role of cytokines in the differentiation of CD4+ T cell subsets in vivo. Immunol. Rev. 1991; 123: 189–207
   PubMed Web of Science ®Google Scholar
• Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFNγ production by T cells. Nature 1995; 378: 88–91
   PubMed Web of Science ®Google Scholar
• Coffman R. L., von der Weid T. Multiple pathways for the initiation of T helper 2 (Th2) responses. J. Exp. Med. 1997; 185: 373–375
   Google Scholar
• Rincon M., Anguita J., Nakamura T., Fikrig E., Flavell R. A. IL-6 directs the differentiation of IL-4-producing CD4+ T cells. J. Exp. Med. 1997; 185: 461–469
   PubMed Web of Science ®Google Scholar
• Gause W. C., Halvorson M. J., Lu P., Greenwald R., Linsley P., Urban J. F., Finkelman F. D. The function of costimulatory molecules and the development of IL-4 producing T cells. Immunol. Today 1997; 18: 115–120
   Google Scholar
• Kalinski P., Hilkens C. M.U., Wierenga E. A., Van der Pouw-Kraan T. C.T.M., Van Lier R. A.W., Bos J. D., Kapsenberg M. L., Snijdewint F. G.M. Functional maturation of human naive T helper cells in the absence of accessory cells. J. Immunol. 1995; 154: 3753–3760
   PubMed Web of Science ®Google Scholar
• Seder R. A., Le Gros G. G. The functional role of CD8+ T helper type 2 cells. J. Exp. Med. 1995; 181: 5–7
   PubMed Web of Science ®Google Scholar
• Erard F., Wild M. T., Garcia-Snaz J. A., Le Gros G. G. Switch of CD8 T cells to noncytolytic CD8- CD4+ cells that make Th2 cytokines and help B cells. Science 1993; 260: 1802–1805
   PubMed Web of Science ®Google Scholar
• Sad S., Marcotte R., Mosmann T. R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271–279
   PubMed Web of Science ®Google Scholar
• Salgame P., Abrams J. S., Clayberger C., Goldstein H., Convit J., Modlin R. L., Bloom B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279–282
   PubMed Web of Science ®Google Scholar
• Paganelli R., Scala E., Ansotegui I. L., Ausiello C. M., Halapi E., Fanales- Belasio E., D'Offizi G., Mezzaroma I., Pandolfi F., Fiorilli M., Cassone A., Aiuti F. CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J. Exp. Med. 1995; 181: 423–428
   Google Scholar
• Uyemura K., Pirmez C., Sieling P. A., Kiene K., Paes-Oliveira M., Modlin R. L. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor. J. Immunol. 1993; 151: 7095–7104
   Google Scholar
• Manetti R., Annunziato F., Biagiotti R., Giudizi M. G., Piccinni M. P., Giannarini L., Sampognaro S., Parronchi P., Vinante F., Pizzolo G., Maggi E., Romagnani S. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+ CD30+ T cell clones in human immunodeficiency virus infection. J. Exp. Med. 1994; 180: 2407–2411
   PubMed Web of Science ®Google Scholar
• Yoshimoto T., Paul W. E. CD4pos, NKl.lpos T cells promptly produce interleukin 4 in response to in vivo, challenge with anti-CD3. J. Exp. Med. 1994; 179: 1285–1295
   PubMed Web of Science ®Google Scholar
• Bendelac A. Mouse NK1 + T cells. Curr. Opinion. Immunol. 1995; 7: 367–374
   PubMed Web of Science ®Google Scholar
• Brunner T., Heusser C. H., Dahinden C. A. Human peripheral blood basophils primed by interleukin-3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 1993; 177: 605–611
   PubMed Web of Science ®Google Scholar
• Li H., Sim T. C., Alam R. IL-13 released by and localized in human basophils. J. Immunol. 1996; 156: 4833–4838
   PubMed Web of Science ®Google Scholar
• Brown M. A., Pierce J. H., Watson C. J., Falco J., Ihle J. N., Paul W. E. B cell stimulatory factor-1/interIeukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987; 50: 809–818
   PubMed Web of Science ®Google Scholar
• Burd P. R., Thompson W. C., Max E. E., Mills F. C. Activated mast cells produce interleukin-13. J. Exp. Med. 1995; 181: 1373–1380
   PubMedGoogle Scholar
• Bradding P., Feather I. H., Howarth P. H., Mueller R., Roberts J. A., Britten K., Bews J. P.A., Hunt T. G., Okayama Y., Heusser C. H. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 1992; 176: 1381–1386
   PubMed Web of Science ®Google Scholar
• Pawankar R., Okuda M., Yssel H., Okumura K., Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRl, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 1997; 99: 1492–1499
   PubMed Web of Science ®Google Scholar
• Moqbel R., Ying S., Barkins J., Newman T. M., Kimmit P., Wakelin M., Taborda-Barata L., Meng Q., Corrigan C. J., Durham S. R., Kay A. B. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J. Immunol. 1995; 155: 4939–4947
   PubMed Web of Science ®Google Scholar
• Kindler V., Matthes T., Jeannin P., Zubler R. H. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking. Eur. J. Immunol. 1995; 25: 1239–1243
   Google Scholar
• Fior R., Vita N., Raphael M., Minty A., Maillot M. C., Crevon M. C., Caput D., Biberfeld P., Ferrara P., Galanaud P., Emilie D. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Eur. Cytokine Netw. 1994; 5: 593–600
   PubMed Web of Science ®Google Scholar
• Defrance T., Aubry J. P., Rousset F., Vanbervliet B., Bonnefoy J. Y., Arai N., Takebe Y., Yokota T., Lee F., Arai K., De Vries J., Banchereau J. Human recombinant interleukin 4 induces Fee receptors (CD23) on normal human B lymphocytes. J. Exp. Med. 1987; 165: 1459–1467
   PubMed Web of Science ®Google Scholar
• Punnonen J., Aversa G., Cocks B. G., McKenzie A. N.J., Menon S., Zurawski G., de Waal Malefyt R., de Vries J. E. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 1993; 90: 3730–3734
   PubMed Web of Science ®Google Scholar
• Chaouchi N., Wallon C., Goujard C., Tertian G., Rudent A., Caput D., Ferrera P., Minty A., Vazquez A., Delfraissy J. F. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro, apoptosis. Blood 1996; 87: 1022–1029
   PubMed Web of Science ®Google Scholar
• Shields J. G., Armitage R., Jamieson B. N., Beverley P. C.L., Callard R. E. Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4. Immunol. 1989; 66: 224–227
   PubMed Web of Science ®Google Scholar
• Vallé A., Aubry J. P., Durand I., Banchereau J. IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism forT-B cell interactions. Int. Immunol. 1991; 3: 229–235
   PubMed Web of Science ®Google Scholar
• Banchereau J., Bazan F., Blanchard D., Brière F., Galizzi J. P., van Kooten C., Liu Y. J., Rousset F., Saeland S. The CD40 antigen and its Ligand. Ann. Rev. Immunol. 1994; 12: 881–922
   PubMed Web of Science ®Google Scholar
• Van Kooten C., Banchereau J. CD40-CD40 ligand, a multifunctional receptor-ligand pair. Adv. Immunol. 1995; 61: 1–77
   Google Scholar
• Smeland E. B., Blomhoff H. K., Funderud S., Shalaby M. R., Espevik T. Interleukin 4 induces selective production of Interleukin 6 from normal human B lymphocytes. J. Exp. Med. 1989; 170: 1463–1468
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Aubry J. P., Takebe Y., Arai N., Miyajima A., Yokota T., Lee T., Arai K., de Vries J. E., Banchereau J. B cell growth-promoting activity of recombinant human interleukin-4. J. Immunol. 1987; 139: 1135–1141
   PubMed Web of Science ®Google Scholar
• Cocks B. C., de Waal Malefyt R., Galizzi J. P., de Vries J. E., Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 1993; 5: 657–663
   PubMed Web of Science ®Google Scholar
• Banchereau J., de Paoli P., Valle A., Garcia E., Rousset F. Long term human B cell lines dependent on interleukin 4 and antibody to CD40. Science 1991; 251: 70–72
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Aubry J. P., Banchereau J. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2. J. Exp. Med. 1988; 168: 1321–1337
   PubMed Web of Science ®Google Scholar
• Defrance T., Carayon P., Billian G., Guillemot J. C., Minty A., Caput D., Ferrara P. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 1994; 179: 135–143
   PubMed Web of Science ®Google Scholar
• Karray S., Dautry-Varsat A., Tsudo M., Merle-Beral H., Debré P., Galanaud P. IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells. J. Immunol. 1990; 145: 1152–1158
   PubMed Web of Science ®Google Scholar
• Fluckiger A. C., Briere F., Zurawski G., Bridon J. M., Banchereau J. IL-13 has only a subset of IL-4 like activities on B chronic lymphocytic leukemia cells. Immunology 1994; 83: 397–403
   PubMed Web of Science ®Google Scholar
• Coffman R. L., Ohara J., Bond M. W., Carty J., Zlotnick A., Paul W. E. B cell stimulatory factor-1 enhances the lgE response of lipopolysaccharide-activated B cells. J. Immunol. 1986; 136: 4538–4541
   PubMed Web of Science ®Google Scholar
• Rousset F., Garcia E., Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 1991; 173: 705–710
   PubMed Web of Science ®Google Scholar
• Punnonen J., Cocks B. G., de Vries J. E. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny. J. Immunol. 1995; 155: 4248–42254
   Google Scholar
• Ezernieks J., Schnarr B., Metz K., Duschl A. The human lgE germline promoter is regulated by interleukin-4, interleukin-13, interferon-alpha and interferon-gamma via an interferon-gamma-activated site and its flanking regions. Eur. J. Biochem. 1996; 240: 667–673
   Google Scholar
• Jabara H. H., Loh R., Ramesh K., Vercelli D., Geha R. S. Sequential switching from u to epsilon via gamma4 in human B cells stimulated with IL-4 and hydrocortisone. J. Immunol. 1993; 151: 4528
   PubMed Web of Science ®Google Scholar
• Shapira S. K., Vercelli D., Jabara H. H., Fu S. M., Geha R. S. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 1992; 175: 289–292
   PubMed Web of Science ®Google Scholar
• Gascan H., Gauchat J. F., Roncarolo M. G., Yssel H., Spits H., de Vries J. E. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J. Exp. Med. 1991; 173: 747–750
   PubMed Web of Science ®Google Scholar
• Kühn R., Rajewsky K., Müller W. Generation and analysis of interleukin-4 deficient mice. Science 1991; 254: 707–710
   PubMed Web of Science ®Google Scholar
• Tepper R. I., Levinson D. A., Stanger B. Z., Campos-Torres J., Abbas A. K., Leder P. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell. 1990; 62: 457–467
   PubMed Web of Science ®Google Scholar
• Carballido J. M., Schols D., Namikawa R., Zurawski S., Zurawski G., Roncarolo M. G., de Vries J. E. IL-4 induces human B cell maturation and lgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo, treatment with an IL-4/IL-13 receptor antagonist. J. Immunol. 1995; 155: 4162–4170
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Bond M. W., Coffman R. L., Ohara J., Paul W. E. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 1986; 83: 5654–5658
   PubMed Web of Science ®Google Scholar
• Hu-Li J., Shevach E. M., Mizuguchi J., Ohara J., Mosmann T., Paul W. E. B cell stimulatory factor 1/interleukin 4 is a potent costimulant for normal resting T lymphocytes. J. Exp. Med. 1987; 165: 157–172
   PubMed Web of Science ®Google Scholar
• Harel-Bellan A., Durum S., Muegge K., Abbas A. K., Farrar W. L. Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Th1 and Th2 helper T cell clones. J. Exp. Med. 1988; 168: 2309–2318
   PubMed Web of Science ®Google Scholar
• Gaya A., Alsinet E., Martorell J., Places L., De La Calle O., Yagüe J., Vives J. Inhibitory effect of IL-4 on the sepharose-CD3-induced proliferation of the CD4CD45RO human T cell subset. Int. Immunol. 1990; 2: 685–689
   Google Scholar
• Spits H., Yssel H., Paliard X., Kastelein R., Figdor D., de Vries J. E. Interleukin-4 inhibits interleukin-2 mediated induction of human lymphokine activated killer cells, but not the generation of antigen specific cytotoxic T lymphocytes in mixed leucocyte cultures. J. Immunol. 1988; 141: 29–36
   PubMed Web of Science ®Google Scholar
• Horohov D. W., Crim J. A., Smith P. L., Siegel J. P. IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J. Immunol. 1988; 141: 4217–4223
   PubMed Web of Science ®Google Scholar
• Kawakami Y., Custer M. C., Rosenberg S. A., Lotze M. T. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J. Immunol. 1989; 142: 3452–3461
   PubMed Web of Science ®Google Scholar
• Warren H. S., Kinnear B. F., Phillips J. H., Lanier L. L. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 1995; 154: 5144–5152
   PubMed Web of Science ®Google Scholar
• Banchereau J., Sealand S. Interleukin-4. Growth factors and cytokines in health and disease. 1997; 2A: 85–142
   Google Scholar
• Vellenga E., Dokter W., Halie R. M. Interleukin-4 and its receptor; Modulating effects on immature and mature hematopoietic cells. Leukemia 1993; 7: 1131–1141
   PubMed Web of Science ®Google Scholar
• Sonoda Y., Kuzuyama Y., Tanaka S., Yokota S., Maekawa T., Clark S. C., Abe T. Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture. Blood 1993; 81: 624–630
   PubMed Web of Science ®Google Scholar
• Xi X., Schlegel N., Caen J. P., Minty A., Fournier S., Caput D., Ferrera P., Han Z. C. Differential effects of recombinant human interleukin-13 on the in vitro, growth of human haemopoietic progenitor cells. Br. J. Haematol. 1995; 90: 921–927
   Google Scholar
• Lai Y. H., Heslan J. M., Poppema S., Elliot J. F., Mosmann T. R. Continuous administration of IL-13 to mice induces extramedullary hemopoiesis and monocytosis. J. Immunol. 1996; 156: 3166–3173
   PubMed Web of Science ®Google Scholar
• Sakamoto O., Hashiyama M., Minty A., Ando M., Suda T. Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood 1995; 85: 3487–3493
   PubMed Web of Science ®Google Scholar
• Jacobsen S. E., Okkenhaug C., Veiby O. P., Caput D., Ferrara P., Minty A. Interleukin-13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J. Exp. Med. 1994; 180: 75–82
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R., Figdor C., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J. E. Effects of IL-13 on pheno-type, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by 1FNγ or IL-10. J. Immunol. 1993; 151: 6370–6381
   PubMed Web of Science ®Google Scholar
• Te Velde A. A., Rousset F., Péronne C., de Vries J. E., Figdor C. IL-4 induced expression of Fc,RIIb and soluble Fc,RIIb release from human monocytes is downregulated by IFNα and IFNγ. J. Immunol. 1990; 144: 3052–3059
   Google Scholar
• Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinman R. M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994; 180: 83–93
   PubMed Web of Science ®Google Scholar
• Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994; 179: 1109–1118
   PubMed Web of Science ®Google Scholar
• Piemonti L., Bernasconi S., Luini W., Trobonjaca Z., Minty A., Allavena P., Mantovani A. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur. Cytokine Netw. 1995; 6: 245–252
   PubMed Web of Science ®Google Scholar
• Zhou L. J., Tedder T. F. CD 14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 1996; 93: 2588–2592
   PubMed Web of Science ®Google Scholar
• Pickl W. F., Majdic O., Kohl P., Stockl J., Riedl E., Scheinecker C., Bello-Fernandez C., Knapp W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol. 1996; 157: 3850–3859
   PubMed Web of Science ®Google Scholar
• Defife K. M., Jenney C. R., McNally A. K., Colton E., Anderson J. M. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 1997; 158: 3385–3390
   PubMed Web of Science ®Google Scholar
• Hart P. H., Vitti G. F., Burgess D. R., Whitty G. A., Piccoli D. S., Hamilton J. A. Potential anti-inflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. USA 1989; 86: 3803–3807
   PubMed Web of Science ®Google Scholar
• D'Andrea A., Ma X., Aste-Amezaga M., Paganin C., Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J. Exp. Med. 1995; 181: 537–546
   PubMed Web of Science ®Google Scholar
• Vannier E., de Waal Malefyt R., Salazar-Montes A., de Vries J. E., Dinarello C. A. Interleukin-13 (IL-13) induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: inhibition by an IL-4 mutant protein. Blood 1996; 87: 3307–3315
   Google Scholar
• Kambayashi T., Jacob C. O., Strassmann G. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell. Immunol. 1996; 171: 153–158
   PubMedGoogle Scholar
• Sebire G., Delfraissy J. F., Demotes-Mainard J., Oteifeh A., Emilie D., Tardieu M. Interleukin-13 and interleukin-4 act as inducers in human microglial cells. Cytokine 1996; 8: 636–641
   Google Scholar
• Corcoran M. L., Stetler-Stevenson W. G., Brown P. D., Wahl L. M. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 1992; 267: 515–519
   PubMedGoogle Scholar
• Abramson S. L., Gallin J. I. IL-4 inhibits superoxide production by human mononuclear phagocytes. J. Immunol. 1990; 144: 625–63
   Google Scholar
• Endo T., Ogushi F., Sone S. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma. J. Immunol. 1996; 156: 2240–2246
   PubMed Web of Science ®Google Scholar
• Yano S., Sone S., Nishioka Y., Mukaida N., Matsushima K., Ogura T. Differential effects of anti-inflammatory cytokines (IL-4, IL-10 and IL-13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemoractic and activating factor. J. Leukoc. Biol. 1995; 57: 303–309
   PubMed Web of Science ®Google Scholar
• Weiss G., Bodgan C., Hentze M. W. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J. Immunol. 1997; 158: 420–425
   PubMed Web of Science ®Google Scholar
• Deng W., Ohmori Y., Hamilton T. A. Mechanisms of IL-4-mediated suppression of IP-gene expression in murine macrophages. J. Immunol. 1994; 153: 2130–2136
   Google Scholar
• Vasse M., Paysant I., Soria J., Mirshahi S. S., Vannier J. P., Soria C. Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Br. J. Haematol. 1996; 93: 955–9961
   PubMed Web of Science ®Google Scholar
• Gautam S. C., Chikkala N. F., Hamilton T. A. Anti-inflammatory action of IL-4. J. Immunol. 1992; 148: 1411–1415
   Google Scholar
• Muchamuel T., Menon S., Pisacane P., Howard M. C., Cockayne D. A. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia. J. Immunol. 1997; 158: 2898–2903
   PubMed Web of Science ®Google Scholar
• Riemann D., Kehlen A., Langner J. Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin. Exp. Immunol. 1995; 100: 277–283
   PubMedGoogle Scholar
• Van Hal P. T.W., Hopstaken-Broos J. P.M., Prins A., Favaloro E. J., Huijbens R. J.F., Hilvering C., Figdor C. G., Hoogsteden H. C. Potential indirect antiinflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC 3.4.11.2). J. Immunol. 1994; 153: 2718–2728
   Google Scholar
• Nassar G. M., Morrow J. D., Roberts L. J., Lakkis F. G., Badr K. F. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J. Biol. Chem. 1994; 269: 27631–27634
   PubMed Web of Science ®Google Scholar
• Lehn M., Weiser W. Y., Engelhorn S., Gillis S., Remold H. G. IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-γ. J. Immunol. 1989; 143: 3020–3024
   PubMedGoogle Scholar
• Kumaratilake L. M., Ferrante A. IL-4 inhibits macrophage-mediated killing of Plasmodium Falciparum in vitro. J. Immunol. 1992; 149: 194–199
   PubMed Web of Science ®Google Scholar
• Montanier L. J., Doyle A. G., Collin M., Herbein G., Illei P., James W., Minty A., Caput D., Ferrara P., Gordon S. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J. Exp. Med. 1993; 178: 743–747
   Google Scholar
• Mikovits J. A., Meyers A. M., Ortaldo J. R., Minty A., Caput D., Ferrara P., Ruscetti F. W. IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes. J. Leukoc. Biol. 1994; 56: 340–346
   Google Scholar
• Baskar P., Silberstein D. S., Pincus S. H. Inhibition of IgG-triggered human eosinophil function by IL-4. J. Immunol. 1990; 144: 2321–2326
   Google Scholar
• Luttmann W., Knoechel B., Foerster M., Matthys H., Virchow J. C., Kroegel C. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J. Immunol. 1996; 157: 1678–1683
   PubMed Web of Science ®Google Scholar
• Bober L. A., Waters T. A., Pugliese-Sivo C. C., Sullivan L. M., Narula S. K., Grace M. J. IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clin. Exp. Immunol. 1995; 99: 129–136
   PubMed Web of Science ®Google Scholar
• Wertheim W. A., Kunkel S. L., Standiford T. J., Burdick M. D., Becker F. S., Wilke C. A., Gilbert A. R., Strieter R. M. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 1993; 151: 2166–2175
   PubMedGoogle Scholar
• Girard D., Paquin R., Naccache P. H., Beaulieu A. D. Effects on interleukin-13 on human neutrophil functions. J. Leukoc. Biol. 1996; 59: 412–419
   Google Scholar
• Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J. G., Dower S. K., Sims J. E., Mantovani A. Interleukin-1 Type II receptor: as a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472–475
   PubMed Web of Science ®Google Scholar
• Colotta F., Re F., Muzio M., Polentarutti N., Minty A., Caput D., Ferrara P., Mantovani A. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol Chem. 1994; 269: 12403–12406
   Google Scholar
• Nilsson G., Nilsson K. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur. J. Immunol. 1995; 25: 870–873
   PubMed Web of Science ®Google Scholar
• Postlethwaite A. E., Seyer J. M. Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70–88 and 89–122. J. Clin. Invest. 1991; 87: 2147–2152
   PubMedGoogle Scholar
• Gillery P., Fertin C., Nicolas J. F., Chastang F., Kalis B., Banchereau J., Maquart F. X. Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. FEBS Lett. 1992; 302: 231–234
   PubMed Web of Science ®Google Scholar
• Postlethwaite A. E., Holness M. A., Katai H., Raghow R. Human fibroblasts synthetize elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest. 1992; 90: 1479–1485
   PubMed Web of Science ®Google Scholar
• Wegrowski Y., Paltot V., Gillery P., Kalis B., Randoux A., Maquart F. X. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. Biochem. J. 1995; 307: 673–678
   PubMed Web of Science ®Google Scholar
• Katz Y., Stav D., Barr J., Passwell J. H. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumor necrosis factor (TNF)-stimulated fibroblasts. Clin. Exp. Immunol. 1995; 101: 150–156
   Google Scholar
• Dechanet J., Briolay J., Rissoan M. C., Chomarat P., Galizzi J. P., Banchereau J., Miossec P. Interleukin 4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J. Immunol. 1993; 151: 4908–4917
   Google Scholar
• Dechanet J., Taupin J. L., Chomarat P., Rissoan M. C., Moreau J. F., Banchereau J., Miossec P. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur. J. Immunol. 1994; 24: 3222–3228
   PubMed Web of Science ®Google Scholar
• Schlaak J. F., Schwarting A., Knolle P., Meyer zum Buschenfelde K. H., Mayet W. Effects of Th1 and Th2 cytokines on cytokine production and 1CAM-1 expression on synovial fibroblasts. Ann. Rheum. Dis. 1995; 54: 560–565
   PubMedGoogle Scholar
• Tushinski R. J., Larsen A., Park L. S., Spoor E. Interleukin 4 alone or in combination with interleukin 1 stimulates 3T3 fibroblasts to produce colony-stimulating factors. Exp. Hematol. 1991; 19: 238–244
   PubMed Web of Science ®Google Scholar
• Seitz M., Loetscher P., Dewald B., Towbin H., Baggiolini M. Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells. Eur. J. Immunol. 1996; 26: 2198–2202
   Google Scholar
• Piela-Smith T. H., Broketa G., Hand A., Korn J. H. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J. Immunol. 1992; 148: 1375–1381
   Google Scholar
• Toi M., Bicknell R., Harris A. L. Inhibition of colon and breast carcinoma cell growth by Interleukin-4. Cancer Res. 1992; 52: 275–279
   PubMed Web of Science ®Google Scholar
• Thornhill M. H., Wellicome S. M., Mahiouz D. L., Lanchbury J. S.S., Kyan-Aung U., Haskard D. O. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and-independent binding mechanisms. J. Immunol. 1991; 146: 592–598
   PubMed Web of Science ®Google Scholar
• Palmer-Crocker R. L., Pober J. S. IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. J. Immunol. 1995; 154: 2838–2845
   PubMedGoogle Scholar
• Lugli S. M., Feng N., Heim M. H., Adam M., Schnyder B., Etter H., Yamage M., Eugster H. P., Lutz R. A., Zurawski G., Moser R. Tumor necrosis factor α enhances the expression of the interleukin (IL)-4 receptor α-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation. J. Biol Chem. 1997; 272: 5487–5494
   PubMedGoogle Scholar
• Moser R., Fehr J., Bruijnzeel P. L.B. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 1992; 149: 1432–1438
   PubMed Web of Science ®Google Scholar
• Valent P., Bevec D., Maurer D., Besemer J., Di Padova F., Butterfield J. H., Speiser W., Majdic O., Lechner K., Bettelheim P. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Immunol. 1991; 88: 3339–3342
   Google Scholar
• Thornhill M. H., Kaskard D. O. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ. J. Immunol. 1990; 145: 865–872
   PubMed Web of Science ®Google Scholar
• Kotowicz K., Callard R. E., Friedrich K., Matthews D. J., Klein N. Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. Int. Immunol. 1996; 8: 1915–1925
   PubMed Web of Science ®Google Scholar
• Klein N. J., Rigley K. P., Callard R. E. IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23. Int. Immunol. 1993; 5: 293–301
   Google Scholar
• Iademarco M. F., Barks J. L., Dean D. C. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J. Clin. Invest. 1995; 95: 264–271
   PubMed Web of Science ®Google Scholar
• Briscoe D. M., Cotran R. S., Pober J. S. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo., Correlation with CD3+ T cell infiltration. J. Immunol. 1992; 149: 2954–2960
   PubMed Web of Science ®Google Scholar
• Sironi M., Sciacca F. L., Matteuci C., Conni M., Vecchi A., Bernasconi S., Minty A., Caput D., Ferrara P., Colotta F., Mantovani A. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994; 84: 1913–1921
   Google Scholar
• Howells G., Pham P., Taylor D., Foxwell B., Feldman M. Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-γ. Eur. J. Immunol. 1991; 21: 97–101
   PubMed Web of Science ®Google Scholar
• Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T. J., Galanaud P., Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J. Immunol. 1995; 154: 1870–1878
   PubMedGoogle Scholar
• Herbert J. M., Savi P., Laplace M. C., Lale A., Dol F., Dumas A., Labit C., Minty A. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett. 1993; 328: 268–270
   PubMed Web of Science ®Google Scholar
• Rousselet G., Busson P., Billaud M., Guillon J. M., Scamps C., Wakasugi H., Lenoir G., Tursz T. Structure and regulation of the Blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinoma. Int. Immunol. 1990; 2: 1159–1166
   Google Scholar
• Phillips J. O., Everson M. P., Moldoveanu Z., Lue C., Mestecky J. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J. Immunol. 1990; 145: 1740–1744
   PubMed Web of Science ®Google Scholar
• Galy A. H., Spits H. IL-1, IL-4, and IFN-γ differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells. J. Immunol. 1991; 147: 3823–3830
   PubMed Web of Science ®Google Scholar
• Kolios G., Robertson D. A., Jordan N. J., Minty A., Caput D., Ferrara P., Westwick J. Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13. Br. J. Immunol. 1996; 119: 351–359
   Google Scholar
• Berkman N. Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human epithelial cells. Immunology 1996; 89: 363–367
   Google Scholar
• Berkman N., Robichaud A., Krishnan V. L., Roesems G., Robbins R., Jose P. J., Barnes P. J., Chung K. F. Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10,-13. Immunology 1996; 87: 599–603
   Google Scholar
• Zund G., Madara J. L., Dzus A. L., Awtrey C. S., Colgan S. P. Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. J. Biol. Chem. 1996; 271: 7460–7464
   PubMed Web of Science ®Google Scholar
• Loyer P., Ilyin G., Razzak Z. A., Dézier J. F., Banchereau J., Campion J. P., Guguen-Guillouzo C., Guillouzo A. IL-4 modulates production of acute phase proteins in adult human hepatocytes. FEBS Lett. 1993; 336: 215–220
   Google Scholar
• Grunfeld C., Soued M., Adi S., Moser A. H., Fiers W., Dinarello C. A., Feingold K. R. Interleukin-4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin-1 and interleukin-6 but not interferon-α. Cancer Res. 1991; 51: 2803–2807
   PubMed Web of Science ®Google Scholar
• Razzak Z. A., Loyer P., Fautrel A., Gautier J. C., Corcos L., Turlin B., Beaune P., Guillouzo A. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 1993; 44: 707–715
   Google Scholar
• Parronchi P., De Carli M., Manetti R., Simonelli C., Piccini M. P., Macchia D., Maggi E., Del Prete G., Ricci M., Romagnani S. Aberrant interleukin (IL)4 and IL5 production in vitro, by CD4+ helper T cells from atopic subjects. Eur. J. Immunol. 1992; 87: 58–69
   Google Scholar
• Lester M. R., Hofer M. F., Gately M., Trumble A., Leung D. Y.M. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis. J. Immunol. 1995; 154: 6174–6181
   PubMedGoogle Scholar
• Rousset F., Robert J., Andary M., Bonnin J. P., Souillet G., Chretien I., Briere F., Pene J., de Vries J. E. Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol. 1991; 87: 58–69
   Google Scholar
• Jutel M., Pichler W. J., Skrbic D., Urwyler A., Dahinden C., Müller U. R. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 1995; 154: 4187–4194
   PubMed Web of Science ®Google Scholar
• Secrist H., Chelen C. J., Wen Y., Marshall J. D., Umetsu D. T. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J. Exp. Med. 1993; 178: 2123–2130
   PubMed Web of Science ®Google Scholar
• Vollenweider S., Saurat J. H., Rocken M., Hauser C. Evidence suggesting involvement of interleukin-4 (IL-4) production in spontaneous in vitro, IgE synthesis in patients with atopic dermatitis. J. Allergy Clin. Immunol. 1991; 87: 1088–1095
   PubMed Web of Science ®Google Scholar
• Levy F., Kristofic C., Heusser C., Brinkmann V. Role of IL-13 in CD4 T cell-dependent IgE production in atopy. Int. Arch. Allergy. Immunol. 1997; 112: 49–58
   Google Scholar
• Reddy M. M., Weissman A. M., Mazza D. S., Meriney D. K., Johns M., Carrabis S., Grieco M. H. Circulating elevated levels of soluble CD23, interleukin 4, and CD20+ CD23+ lymphocytes in atopic subjects with elevated serum IgE concentrations. Ann. Allergy 1992; 69: 131–134
   PubMedGoogle Scholar
• Kapsenberg M. L., Wierenga E. A., Van Der Heijden F. L., Bos J. D. Atopic dermatitis and CD4+ atopen-specific Th2 lymphocytes. Eur. J. Dermatol. 1992; 8: 601–607
   Google Scholar
• Parronchi P., Macchia D., Piccini M. P., Biswas P., Simonelli C., Maggi E., Ricci M., Ansari A. A., Romagnani S. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 1991; 88: 4538–4542
   PubMed Web of Science ®Google Scholar
• Secrist H., DeKruyff R. H., Umetsur D. T. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 1995; 181: 1081–1089
   Web of Science ®Google Scholar
• Marsh D. G., Neely J. D., Breazeale D. R., Ghosh B., Freidhoff L. R., Ehrlich-Kautzky E., Schou C., Krishnaswamy G., Beaty T. H. Linkage analysis of 1L4 and other chromosome 5q31–1 markers and total serum immunoglobulin E concentrations. Science 1994; 264: 1152–1156
   PubMed Web of Science ®Google Scholar
• Tepper R. I., Pattengale P. K., Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989; 57: 503–512
   PubMed Web of Science ®Google Scholar
• Tepper R. I., Coffman R. L., Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992; 257: 548–551
   PubMed Web of Science ®Google Scholar
• Bosco M. C., Giovarelli M., Forni M., Modesti A., Scarpa G., Masuelli L., Forni G. Low doses of interleukin 4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J. Immunol. 1990; 145: 3136–3143
   PubMed Web of Science ®Google Scholar
• Golumbek P. T., Lazenby A. J., Levitsky H. I., Jaffee L. M., Karasuyama H., Baker M., Pardoll D. M. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 1991; 254: 713–716
   PubMed Web of Science ®Google Scholar
• Lebel-Binay S., Laguerre B., Quintin-Colonna F., Conjeaud H., Magazin M., Miloux B., Pecceu F., Caput D., Ferrara P., Fradelizi D. Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13. Eur. J. Immunol. 1995; 25: 2340–2348
   Google Scholar
• Pandrau D., Saeland S., Duvert V., Durand I., Manel A. M., Zabot M X, Philippe N., Banchereau J. Interleukin-4 inhibits in vitro, proliferation of leukemic and normal human B cell precursors. J. Clin. Invest. 1992; 90: 1697–1706
   PubMed Web of Science ®Google Scholar
• Akashi K., Shibuya T., Harada M., Takamatsu Y., Uike N., Eto T., Niho Y. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. J. Clin. Invest. 1991; 88: 223–230
   PubMed Web of Science ®Google Scholar
• Obiri N. I., Hillman G. G., Haas G. P., Sud S., Puri R. K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro, by interleukin-4. J. Clin. Invest. 1993; 91: 88–93
   PubMed Web of Science ®Google Scholar
• Renard N., Duvert V., Banchereau J., Saeland S. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. Blood 1994; 84: 2253–2260
   PubMed Web of Science ®Google Scholar
• Bruserud O. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts. Leukemia 1996; 10: 1497–1503
   PubMed Web of Science ®Google Scholar
• Topp M. S., Koenigsmann M., Mire-Sluis A., Oberberg D., Eitelbach F., Von Marschall Z., Notter M., Reufi B., Stein H., Thiel E., Berdel W. E. Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro, and in vivo. Blood 1993; 82: 2837–2844
   PubMed Web of Science ®Google Scholar
• Topp M. S., Papadimitriou C. A., Eitelbach F., Koenigsmann M., Oelmann E., Koehler B., Oberberg D., Reufi B., Stein H., Thiel E., et al. Recombinant human interleukin-4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res. 1995; 55: 2173–2176
   PubMed Web of Science ®Google Scholar
• Serve H., Oelmann E., Herweg A., Oberberg D., Serve S., Reufi B., Mucke C., Minty A., Thiel E., Berdel W. E. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Res. 1996; 56: 3583–3588
   Google Scholar
• Puri R. K., Leland P., Obiri N. I., Husain S. R., Kreitman R. J., Haas G. P., Pastan I., Debinski W. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Blood 1996; 87: 4333–4339
   PubMed Web of Science ®Google Scholar
• Hurford R. K., Dranoff G., Mulligan R. C., Tepper R. I. Gene therapy of metastatic cancer by in vivo, retroviral gene targeting. Nature Genetics 1995; 10: 430–435
   PubMed Web of Science ®Google Scholar
• Miossec P., Briolay J., Dechanet J., Wijdenes J., Martinez-Valdez H., Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo, model of rheumatoid synovitis. Arthritis Rheum. 1992; 35: 874–883
   PubMedGoogle Scholar
• Hart P. H., Ahernn M. J., Smith M. D., Finlay-Jones J. J. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin. Exp. Immunol. 1995; 99: 331–337
   PubMed Web of Science ®Google Scholar
• Chomarat P., Banchereau J., Miossec P. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum. 1995; 38: 1046–1054
   PubMedGoogle Scholar
• Kucharzik T., Lügering N., Weigelt H., Adolf M., Domschke W., Stoll R. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin. Exp. Immunol. 1996; 104: 483–490
   PubMedGoogle Scholar
• Isomaki P., Luukkainen R., Toivanen P., Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 1996; 39: 1693–1702
   PubMed Web of Science ®Google Scholar
• Miossec P., Chomarat P., Dechanet J., Moreau J. F., Roux J. P., Delmas P., Banchereau J. Interleukin 4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo, model of bone resorption in rheumatoid arthritis. Arthritis Rheum. 1994; 37: 1715–1722
   PubMedGoogle Scholar
• Lacey D. L., Erdmann J. M., Teitelbaum S. L., Tan H. L., Ohara J., Shioi A. Interleukin-4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 1995; 136: 2367–2376
   PubMed Web of Science ®Google Scholar
• Onoe Y., Miyaura C., Kaminakayashiki T., Nagai Y., Noguchi K., Chen Q. R., Seo H., Ohta H., Nozawa S., Kudo I., Suda T. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J. Immunol. 1996; 156: 758–764
   PubMedGoogle Scholar
• Lind M., Deleuran B., Yssel H., Fink-Eriksen E., Thestrup-Pedersen K. IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts. Cytokine 1995; 7: 78–82
   PubMedGoogle Scholar
• Racke M. K., Burnett D., Pak S. H., Albert P. S., Cannella B., Raine C. S., McFarlin D. E., Scott D. E. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 1995; 154: 450–458
   PubMed Web of Science ®Google Scholar
• Shaw M. K., Lorens J. B., Dhawan A., DalCanto R., Tse H. Y., Tran A. B., Bonpane C., Eswaran S. L., Brocke S., Sarvetnick N., Steinman L., Nolan G. P., Fathman C. G. Local delivery of interleukin-4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 1997; 185: 1711–1714
   PubMed Web of Science ®Google Scholar
• Cash E., Minty A., Ferrara P., Caput D., Fradelizi D., Rott O. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 1994; 153: 4258–4267
   PubMed Web of Science ®Google Scholar
• Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185–1188
   PubMed Web of Science ®Google Scholar
• Allen J. B., Wong H. L., Costa G. L., Bienkowski M. J., Wahl S. M. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 1993; 151: 4344–4351
   PubMed Web of Science ®Google Scholar
• Bessis N., Boissier M. C., Ferrara P., Blankenstein T., Fradelizi D., Fournier C. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 1996; 26: 2399–2403
   PubMed Web of Science ®Google Scholar
• Mulligan M. S., Jones M. L., Vaporciyan A. A., Howard M. C., Ward P. A. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 1993; 151: 5666–5674
   PubMed Web of Science ®Google Scholar
• Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Leiter E. H., Cyopick P., Dnaska J. S., Deloviqtch T. L. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 1993; 178: 87–99
   PubMed Web of Science ®Google Scholar